We are live on ! Find out more
BTWM

Baker Tilly Wealth Management Portfolio holdings

AUM $471M
1-Year Est. Return 23.36%
This Fund
S&P 500
This Quarter Est. Return
+7.93%
1 Year Est. Return
+23.36%
3 Year Est. Return
+83.59%
5 Year Est. Return
+103.95%
10 Year Est. Return
AUM
$443M
AUM Growth
+$163M
Cap. Flow
+$138M
Cap. Flow %
31.17%
Top 10 Hldgs %
34.13%
Holding
281
New
47
Increased
130
Reduced
85
Closed
6

Sector Composition

Rank Sector Weight
1 Miscellaneous 56.66%
2 Technology 12.76%
3 Financials 6.93%
4 Communication Services 5.52%
5 Consumer Discretionary 4.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WFC icon
101
Wells Fargo
WFC
$263B
$836K 0.19%
9,971
+1,792
+22% +$145K
NOC icon
102
Northrop Grumman
NOC
$74.4B
$822K 0.19%
1,348
-314
-19% -$178K
NVO
103
Novo Nordisk
NVO
$191B
$807K 0.18%
14,544
+1,996
+16% +$117K
CVX icon
104
Chevron
CVX
$415B
$800K 0.18%
5,153
+403
+8% +$62.4K
SPDW icon
105
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$41.8B
$797K 0.18%
18,617
+1,901
+11% +$78.8K
AVB
106
DELISTED
AvalonBay Communities
AVB
$779K 0.18%
4,031
+507
+14% +$98.7K
KKR icon
107
KKR & Co
KKR
$88.1B
$766K 0.17%
5,893
-40
-0.7% -$5.68K
IUSV icon
108
iShares Core S&P US Value ETF
IUSV
$27.4B
$764K 0.17%
+7,648
New +$744K
IBM icon
109
IBM
IBM
$224B
$761K 0.17%
2,697
+1,337
+98% +$350K
FCX icon
110
Freeport-McMoran
FCX
$102B
$753K 0.17%
19,198
-1,236
-6% -$53.6K
APO icon
111
Apollo Global Management
APO
$74.4B
$752K 0.17%
5,642
+57
+1% +$8.07K
AZN icon
112
AstraZeneca
AZN
$258B
$744K 0.17%
4,850
+133
+3% +$20.1K
WM icon
113
Waste Management
WM
$85.3B
$743K 0.17%
3,362
-103
-3% -$23.2K
DFAI
114
Dimensional International Core Equity Market ETF
DFAI
$18.1B
$741K 0.17%
+20,390
New +$721K
LHX icon
115
L3Harris
LHX
$46.6B
$739K 0.17%
2,420
-128
-5% -$35K
ACN icon
116
Accenture
ACN
$116B
$736K 0.17%
2,986
+779
+35% +$203K
APD icon
117
Air Products & Chemicals
APD
$63.7B
$729K 0.16%
2,672
+14
+0.5% +$4.05K
REGN icon
118
Regeneron Pharmaceuticals
REGN
$81.3B
$722K 0.16%
1,284
+4
+0.3% +$2.26K
VTI icon
119
Vanguard Morningstar Total Stock Market ETF
VTI
$685B
$717K 0.16%
2,186
CBRE icon
120
CBRE Group
CBRE
$40.3B
$709K 0.16%
4,502
+928
+26% +$144K
TEL icon
121
TE Connectivity
TEL
$59.8B
$698K 0.16%
3,179
-82
-3% -$16.4K
SDY icon
122
State Street SPDR S&P Dividend ETF
SDY
$21.2B
$683K 0.15%
4,877
SCHB icon
123
Schwab US Broad Market ETF
SCHB
$44.3B
$683K 0.15%
26,552
-322
-1% -$7.97K
CWI icon
124
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.86B
$674K 0.15%
19,306
LYV icon
125
Live Nation Entertainment
LYV
$39.2B
$666K 0.15%
4,075
+657
+19% +$104K

Similar funds

Baker Tilly Wealth Management's Q3 2025 Portfolio in Review

As of Q3 2025, Baker Tilly Wealth Management held 281 positions worth $443M, up 58% from $280M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Baker Tilly Wealth Management deployed $138M of net new capital in Q3 2025, opening 47 new positions and adding to 130 existing holdings. Its largest new stake was Dimensional US Equity ETF: 130,666 shares worth $9.47M.

By sector, the portfolio is most concentrated in Miscellaneous at 57% of assets, up from 39% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Oracle, an estimated $412K trimmed.

  • Baker Tilly Wealth Management's largest Q3 2025 buy was Dimensional US Equity ETF: 130,666 shares worth $9.47M.
  • Baker Tilly Wealth Management added most to Dimensional US Targeted Value ETF in Q3 2025, an estimated $19.1M increase.
  • Baker Tilly Wealth Management's biggest Q3 2025 reduction was Oracle, cutting an estimated $412K.
  • Baker Tilly Wealth Management fully exited Gartner in Q3 2025, selling an estimated $388K.
  • Baker Tilly Wealth Management's ten largest holdings make up 34% of its $443M portfolio in Q3 2025.
  • Baker Tilly Wealth Management opened 47 new positions and closed 6 in Q3 2025.
  • Baker Tilly Wealth Management's portfolio value rose 58% quarter-over-quarter to $443M.

Based on Baker Tilly Wealth Management's 13F filing for Q3 2025, filed 9 Oct 2025.